Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibroma 1

Interventions

AZD 6244 9trametinib 4mirdametinib 2fludarabine 2thymoglobulin 1talimogene laherparepvec 1omipalisib 1lorlatinib 1fludarabine phosphate 1encorafenib 1dabrafenib 1cabozantinib 1binimetinib 1abemaciclib 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Radiation 1Melphalan 1Magnetic Resonance Spectroscopy 1Levetiracetam 1Lasers, Solid-State 1Lasers 1Injections 1Inhalation 1Deoxycholic Acid 1Cytarabine 1Cyclophosphamide 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Deoxycholic Acid × 90 days × Clear all
NCT06300502 2026-04-22

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase 1 Enrolling by invitation
15 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡